Values for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluation at end of life
- Publication Type:
- Journal Article
- Citation:
- Social Science and Medicine, 2017, 189 pp. 114 - 128
- Issue Date:
- 2017-09-01
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
Values-for-the-ICECAP-Supportive-Care-Measure--ICECAP-SCM_2017_Social-Scienc.pdf | Published Version | 1.52 MB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
© 2017 Elsevier Ltd End of life care may have elements of value that go beyond health. A generic measure of the benefits of end of life care could be helpful to decision makers. Such a measure, based on the capability approach, has recently been developed: the ICECAP Supportive Care Measure. This paper reports the first valuation exercise for that measure, with data from 6020 individuals collected from an on-line general population panel during June 2013. Individuals were asked to complete a stated choice experiment that combined best-worst scaling and a standard discrete choice experiment. Analysis of the best-worst data used limited dependent variable models within the random utility framework including the multinomial logit models and latent class choice model analysis. Exploratory steps were taken to determine the similarity of the best-worst and DCE data before formal testing and pooling of the two data sources. Combined data were analysed in a heteroscedastic conditional logit model adjusting for continuous scale. Two sets of tariffs were generated, one from the best-worst data capturing only main effects, and a second from the pooled data allowing for two-way interactions. Either tariff could be used in economic evaluation of interventions at the end of life, although there are advantages and disadvantages with each. This extensive valuation exercise for the ICECAP Supportive Care Measure, with a large number of members of the general public, could be complemented in the future with best-worst scaling studies amongst those experiencing the end of life.
Please use this identifier to cite or link to this item: